Tecsys Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2026
Solid FY2026 finish undermined by a jarring 2-4% total revenue growth guide for FY2027, just as bullish expectations had been fully priced in.
Tecsys reported record Q4 total revenue of $50.0M (year-over-year +7%) and record full-year revenue of $193.1M (+9.4% YoY). Total SaaS revenue grew 17% in Q4 and 20% for the year; Elite™ SaaS revenue grew faster (21% Q4, 24% FY). Adjusted EBITDA jumped 56% in Q4 to $6.7M and 50% for the full year to $20.0M, delivering a 10% adjusted EBITDA margin – above the 8-9% guidance. Q4 GAAP net loss was -$0.2M after a $4.7M restructuring charge; adjusted net profit was $3.2M (up from $1.7M a year ago). The company declared a $0.09 dividend and repurchased 207,800 shares for $5.9M in the quarter. Management initiated FY2027 guidance: total revenue growth 2-4%, total SaaS revenue growth 13-15%, Elite™ SaaS revenue growth 18-20%, and adjusted EBITDA margin 11-13%.
The Q4 print itself was operationally sound and delivered the promised FY2026 beat on margins. However, the FY2027 total revenue growth guide of 2-4% is genuinely new and represents a dramatic deceleration. The stock had rallied 35% into the print, implying the market expected ongoing high-single-digit or better topline expansion. The guide conflicts directly with that expectation. While the SaaS engine remains healthy, the headline revenue growth collapse will challenge the valuation and likely trigger a negative repricing. This is a material negative development.
Tecsys Inc. is a Canadian-based provider of supply chain execution software, focused on healthcare and complex distribution environments. The company is transitioning to a SaaS-first model around its Elite™ platform, which addresses warehouse management, pharmacy inventory, and point-of-use visibility. It serves over 1,000 customer sites globally and generates a majority of revenue in USD.